✦ LIBER ✦

Use of deferiprone for iron chelation in patients with transfusion-dependent thalassaemia

✍ Scribed by Saumya Shekhar Jamuar; Angeline Hwei Meeng Lai; Ah Moy Tan; Mei Yoke Chan; Ee Shien Tan; Ivy Swee Lian Ng

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Iron chelation therapy associated with i

✍ Esther Natalie Oliva; Francesca Ronco; Antonio Marino; Caterina Alati; Giulia Pr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Successful chelation therapy with the co

✍ Ersi Voskaridou; Dimitrios Christoulas; Evangelos Terpos 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Australian guidelines for the assessment

✍ P. J. Ho; L. Tay; R. Lindeman; L. Catley; D. K. Bowden 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Consequences and costs of noncompliance

✍ Thomas E. Delea; John Edelsberg; Oleg Sofrygin; Simu K. Thomas; Jean-Francois Ba 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Use of the oral chelator deferiprone in

✍ Joyce C. W. Chan; Chor-Sang Chim; Clara G. C. Ooi; Bernard Cheung; Raymond Liang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Influence of iron chelators on myocardia

✍ Manju Mamtani; Hemant Kulkarni 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB